Journal of Medicinal Chemistry p. 165 - 169 (1978)
Update date:2022-07-29
Topics:
Johnson
Smissman
A number of analogues of the tripeptide L-prolyl-L-leucylglycinamide (1) were synthesized and evaluated in the Dopa potentiation and oxotremorine antagonism tests. The replacement of the glycinamide residue with either the glycine methylamide, glycine, aminoacetronitrile, amino-2-propanone, semicarbazide, or β-alaninamide residues resulted in a loss of activity in both tests. A 1:1 mixture of L-prolyl-L-leucyl-(-)-thiazolidine-2-carboxamide and L-propyl-L-leucyl-(+)-thiazolidine-2-carboxamide showed marked activity in the Dopa potentiation test but was unable to antagonize the tremors induced by oxotremorine. L-prolyl-L-leucyl-L-prolinamide, on the other hand, was active in the oxotremorine antagonism test but inactive in the Dopa potentiation test. The replacement of the pyrrolidine ring of 1 with either a thiazolidine or cyclopentane ring system caused a loss of activity. The cyclopentanecarboxylic acid analogue 13, however, was found to have moderate activity in the serotinin potentiation test.
View MoreChengdu ZY Biochemical Technology Co., LTD
Contact:0086-28-88680086
Address:170 Qingpu Road, Shouan Town, Pujiang County
Wuhan Konberd Biotech Co., Ltd.
Contact:+86-27-87205925
Address:NO.666, Gaoxin Road, Eastlake High-tech zone
Anhui Biochem United Pharmaceutical Co., Ltd.
Contact:0086 551 5167062 / 5228268
Address:No. 30 Hongfeng Road, Hi-Tech Development Zone, Hefei (230088), China
Taizhou Crene Biotechnology co.ltd
Contact:86-576-88813233 88205808
Address:Economic Developed Zone of Taizhou Zhejiang China
Zhengzhou Aixi Pharmtech Co.,Ltd(expird)
Contact:13674977265,
Address:Jinshui District,Zhengzhou City,Nanyang Road
Doi:10.1039/a906839b
(1999)Doi:10.1016/j.tetasy.2003.10.006
(2003)Doi:10.1021/ja00899a044
(1963)Doi:10.1021/ja00958a033
(1966)Doi:10.1016/0040-4039(96)01541-9
(1996)Doi:10.1021/om990322f
(1999)